Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Hyperlipidemias D006949 73 associated lipids
Stomach Ulcer D013276 75 associated lipids
Atherosclerosis D050197 85 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Arteriosclerosis D001161 86 associated lipids
Diabetes Mellitus, Type 2 D003924 87 associated lipids
Seizures D012640 87 associated lipids
Brain Ischemia D002545 89 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Santillan-Doherty P et al. Plasma thromboxane B2 concentrations and pulmonary vascular resistance during lung reperfusion. 1997 Jul-Aug J Invest Surg pmid:9284000
Teraoka S et al. Multicenter trial of the therapeutic effect of a newly developed antiplatelet agent, satigrel, on biopsy-proven chronic rejection after kidney transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9122990
Ishine N et al. Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123045
Suehiro T et al. Value of caval effluent in predicting early graft function after orthotopic liver transplantation. 1997 Feb-Mar Transplant. Proc. pmid:9123086
Yagi T et al. Hepatropic soluble vitamin E derivative EPC-K1 prevents warm ischemia/reperfusion injury of non-heart-beating donor liver transplantation in pigs. 1997 Feb-Mar Transplant. Proc. pmid:9123352
Yamamoto S et al. Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock. 1997 Am. J. Physiol. pmid:9087598
Kume S [Evaluation and problems on platelet function tests]. 1997 Nippon Rinsho pmid:9097565
Yu J and Hu WS [Effects of neferine on platelet aggregation in rabbits]. 1997 Yao Xue Xue Bao pmid:11243209
Hellyer PW et al. Effect of NG-nitro-L-arginine-methyl-ester on cardiopulmonary function and biosynthesis of cyclooxygenase products during porcine endotoxemia. 1997 Crit. Care Med. pmid:9201060
Nanji AA et al. Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the rat. 1997 Gastroenterology pmid:8978360
Berg J et al. Isoenzyme-specific cyclooxygenase inhibitors: a whole cell assay system using the human erythroleukemic cell line HEL and the human monocytic cell line Mono Mac 6. 1997 J Pharmacol Toxicol Methods pmid:9279772
Tanaka M et al. Effects of a thromboxane synthetase inhibitor (OKY-046) in an ischemia-reperfusion model of intrauterine growth retardation in Sprague-Dawley rats. 1997 Biol. Neonate pmid:9303217
Mitra A et al. Thromboxane-mediated alveolar responses to acute obstruction of the pulmonary vasculature. 1997 Am. J. Respir. Crit. Care Med. pmid:9117035
Bröijersén A et al. No influence of simvastatin treatment on platelet function in vivo in patients with hypercholesterolemia. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9081681
Mori TA et al. Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9081682
Hsieh YZ and Kuo KL Analysis of prostaglandins by micellar electrokinetic capillary chromatography. 1997 J Chromatogr A pmid:9084156
Todd MK et al. Comparison of methods for evaluating exercise-induced changes in thromboxane B2 and beta-thromboglobulin. 1997 Med Sci Sports Exerc pmid:9140910
Bishop-Bailey D et al. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture. 1997 Br. J. Pharmacol. pmid:9146896
Shinohara M et al. [Responses to surgical stress in blood coagulation and fibrinolysis, platelet counts and thromboxane B2 after esophageal cancer operation]. 1997 Rinsho Byori pmid:9121003
Cheng Z et al. Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats. 1997 Vet. Rec. pmid:9123796
Yasui K et al. Involvement of thromboxane A2 in antigen-induced nasal blockage in guinea pigs. 1997 Int. Arch. Allergy Immunol. pmid:9104797
Tang QZ et al. [Effect of buyang huanwu decoction on platelet function and fibrinolytic activity of unstable angina pectoris patients]. 1997 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:10322871
Chen SX et al. [Effects of tetramethylpyrazine on platelet functions of advanced cases of lung carcinoma]. 1997 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:10322873
Chong ZZ and Feng YP Effects of dl-3-n-butylphthalide on production of TXB2 and 6-keto-PGF1 alpha in rat brain during focal cerebral ischemia and reperfusion. 1997 Zhongguo Yao Li Xue Bao pmid:10322905
Zingarelli B et al. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity. 1997 Br. J. Pharmacol. pmid:9031736
Alavi N and Singh A Events that stimulate release of thromboxane B2 in passive heymann nephritis. 1997 Proc. Soc. Exp. Biol. Med. pmid:9034135
Carty TJ et al. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models. 1997 Inflamm. Res. pmid:9197987
Keen HL et al. Thromboxane is required for full expression of angiotensin hypertension in rats. 1997 Hypertension pmid:9039120
Rodwell LT et al. Effect of inhaled frusemide and oral indomethacin on the airway response to hypertonic saline challenge in asthmatic subjects. 1997 Thorax pmid:9039247
Nanji AA et al. Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. 1997 Gastroenterology pmid:9041257
Watanabe A et al. Effect of TYB-2285 on lung anaphylaxis in actively sensitized rats. 1997 Gen. Pharmacol. pmid:9013209
Lewis DA et al. Production of endothelium-derived factors from sodded expanded polytetrafluoroethylene grafts. 1997 J. Vasc. Surg. pmid:9013924
Liu CZ and Huang TF Crovidisin, a collagen-binding protein isolated from snake venom of Crotalus viridis, prevents platelet-collagen interaction. 1997 Arch. Biochem. Biophys. pmid:9016825
Yeh SL et al. Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition. 1997 Nutrition pmid:9058445
Feng J et al. Effects of tetramethylpyrazine on the release of PGI2 and TXA2 in the hypoxic isolated rat heart. 1997 Mol. Cell. Biochem. pmid:9059992
Hansen TN and Brockbank KG Increased platelet aggregation due to chilling to 20 degrees C is not related to increased sensitivity to agonists. 1997 Transfusion pmid:9225932
Bräutigam R et al. Arachidonic acid of platelet phospholipids is decreased after extracorporeal removal of plasma low density lipoproteins in patients with familial hypercholesterolemia. 1997 Atherosclerosis pmid:9180250
Rautanen M et al. Experimental fat embolism induces urine 2,3-dinor-6-ketoprostaglandin F1alpha and 11-dehydrothromboxane B2 excretion in pigs. 1997 Crit. Care Med. pmid:9233750
Murthy S et al. Ischemia/reperfusion injury in the rat colon. 1997 Inflammation pmid:9187961
Lahoz C et al. Effects of dietary fat saturation on eicosanoid production, platelet aggregation and blood pressure. 1997 Eur. J. Clin. Invest. pmid:9352251
Desideri N et al. N-omega-carbethoxypentyl-4-quinolones: a new class of leukotriene biosynthesis inhibitors. 1997 Arch. Pharm. (Weinheim) pmid:9230527
Yoshida T et al. Improvement of renal function with selective thromboxane A2 synthetase inhibitor, DP-1904 in lupus nephritis. 1997 Adv. Exp. Med. Biol. pmid:9561116
Müller M In vivo measurement of interstitial TxB2-concentrations in skeletal muscle during ischemia and reperfusion. 1997 Adv. Exp. Med. Biol. pmid:9561122
Arbogast E et al. Intrauterine eicosanoid production in uncomplicated and hypertensive pregnancies: alterations of placental 12-hydroxyeicosatetraenoic acid. 1997 Adv. Exp. Med. Biol. pmid:9561182
Takeda H et al. Time course study for airway inflammation and responsiveness by repeated provocation of aeroantigen in guinea pigs. 1997 Prostaglandins pmid:9491210
Vezza R et al. Antivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism. 1997 Thromb. Haemost. pmid:9408024
Byrne A et al. Continued thromboxane A2 formation despite administration of a platelet glycoprotein IIb/IIIa antagonist in patients undergoing coronary angioplasty. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9409315
Gerdemann R et al. [Effect of flunixin meglumine on plasma prostanoid concentrations in horses with colic in the perioperative period]. 1997 DTW. Dtsch. Tierarztl. Wochenschr. pmid:9410724
Kobayashi T et al. Changes in platelet calcium concentration by thromboxane A2 stimulation in patients with nephrotic syndrome of childhood. 1997 Nephron pmid:9375825
Chavali SR et al. Decreased production of interleukin-1-beta, prostaglandin-E2 and thromboxane-B2, and elevated levels of interleukin-6 and -10 are associated with increased survival during endotoxic shock in mice consuming diets enriched with sesame seed oil supplemented with Quil-A saponin. 1997 Int. Arch. Allergy Immunol. pmid:9338609
Neupert W et al. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases. 1997 Br. J. Pharmacol. pmid:9351505
Zahavi M and Zahavi J Concomitant in vitro platelet hypofunction and increased thromboxane B2 (TXB2) generation and enhanced in vivo platelet activation. A distinct syndrome in thrombosis? 1997 Eur. J. Haematol. pmid:9338626
Supanz S et al. Effects of the novel thromboxane (TXA2) receptor antagonist linotroban on inulin and para-aminohippuric acid clearances in the conscious male and female rat. 1997 Arzneimittelforschung pmid:9342416
Tulppala M et al. Low-dose aspirin in prevention of miscarriage in women with unexplained or autoimmune related recurrent miscarriage: effect on prostacyclin and thromboxane A2 production. 1997 Hum. Reprod. pmid:9262298
Nanji AA et al. Alterations in thromboxane synthase and thromboxane A2 receptors in experimental alcoholic liver disease. 1997 J. Pharmacol. Exp. Ther. pmid:9262373
Tu Y et al. Effect of intra-arachnoid space perfusion on thromboxane A and prostacycline in experimental spinal cord injury. 1997 J. Tongji Med. Univ. pmid:9639784
De La Cruz JP et al. Effects of S-adenosyl-L-methionine on platelet thromboxane and vascular prostacyclin. 1997 Biochem. Pharmacol. pmid:9264331
Serebruany VL et al. Could coenzyme Q10 affect hemostasis by inhibiting platelet vitronectin (CD51/CD61) receptor? 1997 Mol. Aspects Med. pmid:9266521
Li S and Tian H [Oral low-dose magnesium gluconate preventing pregnancy induced hypertension]. 1997 Zhonghua Fu Chan Ke Za Zhi pmid:9642379
Gresele P et al. Platelet activation markers in patients with peripheral arterial disease--a prospective comparison of different platelet function tests. 1997 Thromb. Haemost. pmid:9423790
Berlin I et al. [Comparison between effects of morning and evening administration of effervescent calcium carbasalate (equivalent of 160 mg aspirin) on the gastroduodenal mucosa in healthy volunteers]. 1997 Pathol. Biol. pmid:9309270
Famaey JP In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview. 1997 Inflamm. Res. pmid:9427063
Szebeni J et al. Complement activation and thromboxane secretion by liposome-encapsulated hemoglobin in rats in vivo: inhibition by soluble complement receptor type 1. 1997 Artif Cells Blood Substit Immobil Biotechnol pmid:9242930
He CF et al. Postural vasoregulation and mediators of reperfusion injury in venous ulceration. 1997 J. Vasc. Surg. pmid:9129619
Baskett A et al. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses. 1997 Am. J. Vet. Res. pmid:9361895
Shen ZQ et al. Inhibitory effects of copper-aspirin complex on platelet aggregation. 1997 Zhongguo Yao Li Xue Bao pmid:10072923
Barton MH et al. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin. 1997 Am. J. Vet. Res. pmid:9361896
Zeng S and Guo ZG Mepyramine inhibits platelet activating factor-induced rabbit platelet aggregation: role of intracellular histamine. 1997 Zhongguo Yao Li Xue Bao pmid:10072970
Chen L et al. Cyclooxygenase inhibition decreases nitric oxide synthase activity in human platelets. 1997 Am. J. Physiol. pmid:9362253
Li W et al. [Influence of qi-gong on plasma TXB2 and 6-keto-PGF1 alpha in two TCM types of essential hypertension]. 1997 Hunan Yi Ke Da Xue Xue Bao pmid:10072988
Bar J et al. The regulation of platelet aggregation in vitro by interleukin-1beta and tumor necrosis factor-alpha: changes in pregnancy and in pre-eclampsia. 1997 Thromb. Haemost. pmid:9364994
Yi Z et al. [Changes and evaluation of indexes on treating ganyanghuafengzheng with cerebral infarction by tianlongxifeng granulae]. 1997 Hunan Yi Ke Da Xue Xue Bao pmid:10073023
Walker JS et al. Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders". 1997 Arthritis Rheum. pmid:9365082
Kraft M et al. The effect of salmeterol on nocturnal symptoms, airway function, and inflammation in asthma. 1997 Chest pmid:9149578
John H and Schlegel W Reversed-phase high-performance liquid chromatographic method for the determination of the 11-hydroxythromboxane B2 anomers equilibrium. 1997 J. Chromatogr. B Biomed. Sci. Appl. pmid:9367188
Zeltsman D et al. Pathophysiologic plasma levels of leukotriene C4 in relation to the hemodynamic dysfunction and mediator release of graded bacteremia. 1997 Shock pmid:9110414
Rocha FA et al. PAF modulates eicosanoids and TNF release in immune-complex arthritis in rats. 1997 J Lipid Mediat Cell Signal pmid:9101418
Sun ZT et al. [Clinical and experimental study on treating bronchial asthma with xingbei granule]. 1997 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:9863090
Zhang XY and Qian XM [Clinical study of sudden deafness treated with method of integrated traditional Chinese and Western medicine]. 1997 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:9863112
Wu JX et al. [Effects and mechanism of emodin and sandostatin on pancreatic ischemia in acute haemorrhagic necrotizing pancreatitis]. 1997 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:9863132
Hu DH et al. [Effects of hypoxia and anisodamine on products of TXA2 and PGI2 in cultured intra-pulmonary arteriolar smooth muscle cells]. 1997 Sheng Li Xue Bao pmid:9863190
Li HP et al. [The relationship between the activity of phospholipase A2 and acute hypoxic pulmonary arterial pressure]. 1997 Sheng Li Xue Bao pmid:9863193
Lewis K et al. Effect of neuropeptide Y on bradykinin-induced release of prostacyclin and thromboxane from guinea pig perfused lung. 1997 Can. J. Physiol. Pharmacol. pmid:9276148
Nanji AA et al. Cholesterol supplementation prevents necrosis and inflammation but enhances fibrosis in alcoholic liver disease in the rat. 1997 Hepatology pmid:9214456
Malini PL et al. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor. 1997 Lancet pmid:9217714
Oosaki R et al. Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks. 1997 Int. Arch. Allergy Immunol. pmid:9414142
Fenner H Differentiating among nonsteroidal antiinflammatory drugs by pharmacokinetic and pharmacodynamic profiles. 1997 Semin. Arthritis Rheum. pmid:9219317
Teng CM et al. Antiplatelet effects of some aporphine and phenanthrene alkaloids in rabbits and man. 1997 J. Pharm. Pharmacol. pmid:9255715
De la Cruz JP et al. Effect of erythrocytes and prostacyclin production in the effect of fructose and sorbitol on platelet activation in human whole blood in vitro. 1997 Thromb. Res. pmid:9219331
Abate A et al. Inhibition of mediator release from anaphylactic guinea pig hearts by the novel phospholipase A2 inhibitor 3-(4-octadecylbenzoyl) acrylic acid. 1997 Inflamm. Res. pmid:9297549
Slepko N et al. Reorientation of prostanoid production accompanies "activation" of adult microglial cells in culture. 1997 J. Neurosci. Res. pmid:9260740
Davì G et al. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Evidence derived from the study of peripheral arterial disease. 1997 Circulation pmid:9236419
Johnson RD et al. Aspirin induces increased expression of both prostaglandin H synthase-1 and prostaglandin H synthase-2 in cultured human placental trophoblast. 1997 Am. J. Obstet. Gynecol. pmid:9240586
Fujinishi A et al. Effects of nisoldipine on cytosolic calcium, platelet aggregation, and coagulation/fibrinolysis in patients with coronary artery disease. 1997 Angiology pmid:9194537
Freese R and Mutanen M Alpha-linolenic acid and marine long-chain n-3 fatty acids differ only slightly in their effects on hemostatic factors in healthy subjects. 1997 Am. J. Clin. Nutr. pmid:9280178
Cook ME et al. Comparative effects of nabumetone, sulindac, and ibuprofen on renal function. 1997 J. Rheumatol. pmid:9195523
Hato T et al. Outside-in signaling from integrin alpha IIb beta 3 into platelets in the absence of agonist-induced signaling. 1997 Int. J. Hematol. pmid:9195778
Hishinuma T et al. Microdetermination of the thromboxane B3 gas chromatography-selected-ion monitoring using [18O]thromboxane B3 as an internal standard. 1997 Prostaglandins pmid:9261859
Riendeau D et al. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. 1997 Can. J. Physiol. Pharmacol. pmid:9365818
Barbieri B et al. p-Aminobenzoic acid, but not its metabolite p-acetamidobenzoic acid, inhibits thrombin induced thromboxane formation in human platelets in a non NSAID like manner. 1997 Thromb. Res. pmid:9175234